| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 188 |
| 1 | ASPIRIN | 74 |
| 2 | ASPIRIN 325 MG | 73 |
| 3 | ASPIRIN 81 MG | 73 |
| 4 | FLUOROURACIL | 68 |
| 5 | FLUOROURACIL CREAM, 0.5% | 68 |
| 6 | GEMCITABINE HYDROCHLORIDE | 63 |
| 7 | PREDNISONE | 52 |
| 8 | ETOPOSIDE | 51 |
| 9 | DEXAMETHASONE | 50 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | A AND D OINTMENT | 1 | 0.1667 |
| 1 | DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID | 1 | 0.0667 |
| 2 | CLOCORTOLONE PIVALATE | 1 | 0.0385 |
| 3 | KAOLIN | 1 | 0.0182 |
| 4 | OLODATEROL RESPIMAT INHALATION SPRAY | 4 | 0.0108 |
| 5 | PIVMECILLINAM | 2 | 0.0106 |
| 6 | COAGULATION FACTOR VIIA (RECOMBINANT) | 10 | 0.0037 |
| 7 | PRASTERONE | 10 | 0.0036 |
| 8 | MILRINONE LACTATE | 1 | 0.0036 |
| 9 | DESIPRAMINE HYDROCHLORIDE | 1 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 269 |
| 1 | Corticosteroid [EPC] | 146 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 124 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 114 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 74 |
| 5 | Factor Xa Inhibitor [EPC] | 68 |
| 6 | Proton Pump Inhibitor [EPC] | 51 |
| 7 | Topoisomerase Inhibitor [EPC] | 51 |
| 8 | Benzodiazepine [EPC] | 50 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-coagulant [EPC] | 8 | 0.0021 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | Platinum-based Drug [EPC] | 269 | 0.0010 |
| 3 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 4 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 5 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 6 | Topoisomerase Inhibitor [EPC] | 51 | 0.0007 |
| 7 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 5 | 0.0006 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 26 | 0.0005 |